1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Hypogonadism: new trials by email Literature Review of Hypogonadism trials Research Report on Hypogonadism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Setmelanotide in Acquired Hypothalamic Obesity Setmelanotide, Placebo - Hypothalamic Obesity | Phase 3 | Active not recruiting | Rhythm Pharmaceuticals, Inc. | 143 | 2023-04-26 | 2026-08-10 |
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Gonadal Dysgenesis (1) · Male Urogenital Diseases (1) · Urogenital Abnormalities (1) · Urogenital Diseases (1)
setmelanotide (1)
Rhythm Pharmaceuticals, Inc. (1)
Canada (1) · Germany (1) · Japan (1) · Netherlands (1) · United Kingdom (1) · United States (1)
David Meeker, MD (1)